Merck’s Antiretroviral Isentress More Efficient In Suppressing HIV Among Untreated Patients
Oct 29th 2008Drug InformationHIV / AIDS
Merck’s antiretroviral drug Isentress suppresses levels of HIV in previously untreated patients better than the company’s antiretroviral efavirenz, according to research presented Sunday at a meeting of the American Society of Microbiology and the Infectious Diseases Society of America,
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
